The Myc 3' Wnt-responsive element suppresses colonic tumorigenesis

Molecular and Cellular Biology

Volumn 34, Issue 9, 2014, Pages 1659-1669

  Konsavage, Wesley M ^a   Yochum Jr , Gregory S ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; BETA CATENIN; CASPASE 3; HISTONE H3; MESSENGER RNA; MYC PROTEIN; RNA POLYMERASE II; TRANSCRIPTION FACTOR CDX2; WNT PROTEIN; WNT3A PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; COLON ADENOMA; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DNA STRUCTURE; GENE DELETION; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SMALL INTESTINE TUMOR; STOP CODON; TRANSCRIPTION REGULATION; TUMOR VOLUME; WNT RESPONSIVE ELEMENT;

ANIMALS; BETA CATENIN; CARCINOGENESIS; COLITIS; COLON; COLONIC NEOPLASMS; ENHANCER ELEMENTS, GENETIC; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, APC; GENES, MYC; MICE; MUTATION; PROTO-ONCOGENE PROTEINS C-MYC; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84897531121     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00969-13     Document Type: Article

References (62)

1. Archbold HC, Yang YX, Chen L, Cadigan KM. 2012. How do they do Wnt they do? Regulation of transcription by the Wnt/beta-catenin pathway. Acta Physiol. (Oxf.) 204:74-109. http://dx.doi.org/10.1111/j.1748-1716.2011.02293.x.
2. Yeung TM, Chia LA, Kosinski CM, Kuo CJ. 2011. Regulation of selfrenewal and differentiation by the intestinal stem cell niche. Cell. Mol. Life Sci. 68:2513-2523. http://dx.doi.org/10.1007/s00018-011-0687-5.
3. Clevers H, Nusse R. 2012. Wnt/beta-catenin signaling and disease. Cell 149:1192-1205. http://dx.doi.org/10.1016/j.cell.2012.05.012.
4. MacDonald BT, Tamai K, He X. 2009. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell 17:9-26. http://dx.doi.org/10.1016/j.devcel.2009.06.016.
5. Mosimann C, Hausmann G, Basler K. 2009. Beta-catenin hits chromatin: regulation of Wnt target gene activation. Nat. Rev. Mol. Cell Biol. 10:276-286. http://dx.doi.org/10.1038/nrm2654.
6. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW. 1998. Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512. http://dx.doi.org/10.1126/science.281.5382.1509.
7. Yochum GS, Cleland R, Goodman RH. 2008. A genome-wide screen for beta-catenin binding sites identifies a downstream enhancer element that controls c-Myc gene expression. Mol. Cell. Biol. 28:7368-7379. http://dx.doi.org/10.1128/MCB.00744-08.
8. Dang CV, O'Donnell KA, Zeller KI, Nguyen T, Osthus RC, Li F. 2006. The c-Myc target gene network. Semin. Cancer Biol. 16:253-264. http://dx.doi.org/10.1016/j.semcancer.2006.07.014.
9. Eilers M, Eisenman RN. 2008. Myc's broad reach. Genes Dev. 22:2755-2766. http://dx.doi.org/10.1101/gad.1712408.
10. Fearon ER. 2011. Molecular genetics of colorectal cancer. Annu. Rev. Pathol. 6:479-507. http://dx.doi.org/10.1146/annurev-pathol-011110-130235.
11. Athineos D, Sansom OJ. 2010. Myc heterozygosity attenuates the phenotypes of APC deficiency in the small intestine. Oncogene 29:2585-2590. http://dx.doi.org/10.1038/onc.2010.5.
12. Ignatenko NA, Holubec H, Besselsen DG, Blohm-Mangone KA, Padilla-Torres JL, Nagle RB, de Alboranc IM, Guillen RJ, Gerner EW. 2006. Role of c-Myc in intestinal tumorigenesis of the ApcMin/+ mouse. Cancer Biol. Ther. 5:1658-1664. http://dx.doi.org/10.4161/cbt.5.12.3376.
13. Sansom OJ, Meniel VS, Muncan V, Phesse TJ, Wilkins JA, Reed KR, Vass JK, Athineos D, Clevers H, Clarke AR. 2007. Myc deletion rescues Apc deficiency in the small intestine. Nature 446:676-679. http://dx.doi.org/10.1038/nature05674.
14. Wilkins JA, Sansom OJ. 2008. C-Myc is a critical mediator of the phenotypes of Apc loss in the intestine. Cancer Res. 68:4963-4966. http://dx.doi.org/10.1158/0008-5472.CAN-07-5558.
15. Yekkala K, Baudino TA. 2007. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression. Mol. Cancer Res. 5:1296-1303. http://dx.doi.org/10.1158/1541-7786.MCR-07-0232.
16. Bottomly D, Kyler SL, McWeeney SK, Yochum GS. 2010. Identification of beta-catenin binding regions in colon cancer cells using ChIP-Seq. Nucleic Acids Res. 38:5735-5745. http://dx.doi.org/10.1093/nar/gkq363.
17. Yochum GS, McWeeney S, Rajaraman V, Cleland R, Peters S, Goodman RH. 2007. Serial analysis of chromatin occupancy identifies betacatenin target genes in colorectal carcinoma cells. Proc. Natl. Acad. Sci. U. S. A. 104:3324-3329. http://dx.doi.org/10.1073/pnas.0611576104.
18. Yochum GS, Sherrick CM, MacPartlin M, Goodman RH. 2010. A beta-catenin/TCF-coordinated chromatin loop at MYC integrates 5' and 3' Wnt responsive enhancers. Proc. Natl. Acad. Sci. U. S. A. 107:145-150. http://dx.doi.org/10.1073/pnas.0912294107.
19. Pomerantz MM, Ahmadiyeh N, Jia L, Herman P, Verzi MP, Doddapaneni H, Beckwith CA, Chan JA, Hills A, Davis M, Yao KL, Kehoe SM, Lenz HJ, Haiman CA, Yan CL, Henderson BE, Frenkel B, Barretina J, Bass A, Tabernero J, Baselga J, Regan MM, Manak JR, Shivdasani R, Coetzee GA, Freedman ML. 2009. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat. Genet. 41:882-884. http://dx.doi.org/10.1038/ng.403.
20. Tuupanen S, Turunen M, Lehtonen R, Hallikas O, Vanharanta S, Kivioja T, Bjorklund M, Wei GH, Yan J, Niittymaki I, Mecklin JP, Jarvinen H, Ristimaki A, Di-Bernardo M, East P, Carvajal-Carmona L, Houlston RS, Tomlinson I, Palin K, Ukkonen E, Karhu A, Taipale J, Aaltonen LA. 2009. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nat. Genet. 41:885-890. http://dx.doi.org/10.1038/ng.406.
21. Wright JB, Brown SJ, Cole MD. 2010. Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated singlenucleotide polymorphism in colorectal cancer cells. Mol. Cell. Biol. 30: 1411-1420. http://dx.doi.org/10.1128/MCB.01384-09.
22. Haiman CA, Le Marchand L, Yamamato J, Stram DO, Sheng X, Kolonel LN, Wu AH, Reich D, Henderson BE. 2007. A common genetic risk factor for colorectal and prostate cancer. Nat. Genet. 39:954-956. http://dx.doi.org/10.1038/ng2098.
23. Tomlinson I, Webb E, Carvajal-Carmona L, Broderick P, Kemp Z, Spain S, Penegar S, Chandler I, Gorman M, Wood W, Barclay E, Lubbe S, Martin L, Sellick G, Jaeger E, Hubner R, Wild R, Rowan A, Fielding S, Howarth K, Silver A, Atkin W, Muir K, Logan R, Kerr D, Johnstone E, Sieber O, Gray R, Thomas H, Peto J, Cazier B, Houlston R, Consortium C. 2007. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat. Genet. 39:984-988. http://dx.doi.org/10.1038/ng2085.
24. Zanke BW, Greenwood CMT, Rangrej J, Kustra R, Tenesa A, Farrington SM, Prendergast J, Olschwang S, Chiang T, Crowdy E, Ferretti V, Laflamme P, Sundararajan S, Roumy S, Olivier JF, Robidoux F, Sladek R, Montpetit A, Campbell P, Bezieau S, O'Shea AM, Zogopoulos G, Cotterchio M, Newcomb P, McLaughlin J, Younghusband B, Green R, Green J, Porteous MEM, Campbell H, Blanche H, Sahbatou M, Tubacher E, Bonaiti-Pellie C, Buecher B, Riboli E, Kury S, Chanock SJ, Potter J, Thomas G, Gallinger S, Hudson TJ, Dunlop MG. 2007. Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat. Genet. 39:989-994. http://dx.doi.org/10.1038/ng2089.
25. Ahmadiyeh N, Pomerantz MM, Grisanzio C, Herman P, Jia L, Almendro V, He HH, Brown M, Liu XS, Davis M, Caswell JL, Beckwith CA, Hills A, MacConaill L, Coetzee GA, Regan MM, Freedman ML. 2010. 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC. Proc. Natl. Acad. Sci. U. S. A. 107:9742-9746. http://dx.doi.org/10.1073/pnas.0910668107.
26. Sotelo J, Esposito D, Duhagon MA, Banfield K, Mehalko J, Liao HL, Stephens RM, Harris TJR, Munroe DJ, Wu XL. 2010. Long-range enhancers on 8q24 regulate c-Myc. Proc. Natl. Acad. Sci. U. S. A. 107: 3001-3005. http://dx.doi.org/10.1073/pnas.0906067107.
27. Yochum GS. 2011. Multiple Wnt/beta-catenin responsive enhancers align with the MYC promoter through long-range chromatin loops. PLoS One 6:e18966. http://dx.doi.org/10.1371/journal.pone.0018966.
28. Konsavage WM, Jin G, Yochum GS. 2012. The Myc 3' Wnt-responsive element regulates homeostasis and regeneration in the mouse intestinal tract. Mol. Cell. Biol. 32:3891-3902. http://dx.doi.org/10.1128/MCB.00548-12.
29. Sur IK, Hallikas O, Vaharautio A, Yan J, Turunen M, Enge M, Taipale M, Karhu A, Aaltonen LA, Taipale J. 2012. Mice lacking a Myc enhancer that includes human SNP rs6983267 are resistant to intestinal tumors. Science 338:1360-1363. http://dx.doi.org/10.1126/science.1228606.
30. Konsavage WM, Jr, Roper JN, Ishmael FT, Yochum GS. 2013. The Myc 3' Wnt responsive element regulates neutrophil recruitment after acute colonic injury in mice. Dig. Dis. Sci. 58:2858-2867. http://dx.doi.org/10.1007/s10620-013-2686-x.
31. Sato T, Stange DE, Ferrante M, Vries RG, Van Es JH, Van den Brink S, Van Houdt WJ, Pronk A, Van Gorp J, Siersema PD, Clevers H. 2011. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. Gastroenterology 141: 1762-1772. http://dx.doi.org/10.1053/j.gastro.2011.07.050.
32. Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M, Danenberg E, Clarke AR, Sansom OJ, Clevers H. 2009. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457: 608-611. http://dx.doi.org/10.1038/nature07602.
33. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, Kagnoff MF, Karin M. 2004. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118:285-296. http://dx.doi.org/10.1016/j.cell.2004.07.013.
34. Mahmoudi T, Li VS, Ng SS, Taouatas N, Vries RG, Mohammed S, Heck AJ, Clevers H. 2009. The kinase TNIK is an essential activator of Wnt target genes. EMBOJ. 28:3329-3340. http://dx.doi.org/10.1038/emboj.2009.285.
35. Su LK, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR, Luongo C, Gould KA, Dove WF. 1992. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256:668-670. http://dx.doi.org/10.1126/science.1350108.
36. Lin CY, Loven J, Rahl PB, Paranal RM, Burge CB, Bradner JE, Lee TI, Young RA. 2012. Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151:56-67. http://dx.doi.org/10.1016/j.cell.2012.08.026.
37. Nie Z, Hu G, Wei G, Cui K, Yamane A, Resch W, Wang R, Green DR, Tessarollo L, Casellas R, Zhao K, Levens D. 2012. c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 151:68-79. http://dx.doi.org/10.1016/j.cell.2012.08.033.
38. Finch AJ, Soucek L, Junttila MR, Swigart LB, Evan GI. 2009. Acute overexpression of Myc in intestinal epithelium recapitulates some but not all the changes elicited by Wnt/beta-catenin pathway activation. Mol. Cell. Biol. 29:5306-5315. http://dx.doi.org/10.1128/MCB.01745-08.
39. Murphy DJ, Junttila MR, Pouyet L, Karnezis A, Shchors K, Bui DA, Brown-Swigart L, Johnson L, Evan GI. 2008. Distinct thresholds govern Myc's biological output in vivo. Cancer Cell 14:447-457. http://dx.doi.org/10.1016/j.ccr.2008.10.018.
40. Sancho E, Batlle E, Clevers H. 2004. Signaling pathways in intestinal development and cancer. Annu. Rev. Cell Dev. Biol. 20:695-723. http://dx.doi.org/10.1146/annurev.cellbio.20.010403.092805.
41. Heintzman ND, Stuart RK, Hon G, Fu YT, Ching CW, Hawkins RD, Barrera LO, Van Calcar S, Qu CX, Ching KA, Wang W, Weng ZP, Green RD, Crawford GE, Ren B. 2007. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 39:311-318. http://dx.doi.org/10.1038/ng1966.
42. Sierra J, Yoshida T, Joazeiro CA, Jones KA. 2006. The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes. Genes Dev. 20:586-600. http://dx.doi.org/10.1101/gad.1385806.
43. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H. 1997. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/-colon carcinoma. Science 275:1784-1787. http://dx.doi.org/10.1126/science.275.5307.1784.
44. Clevers H. 2013. The intestinal crypt, a prototype stem cell compartment. Cell 154:274-284. http://dx.doi.org/10.1016/j.cell.2013.07.004.
45. Hinoi T, Akyol A, Theisen BK, Ferguson DO, Greenson JK, Williams BO, Cho KR, Fearon ER. 2007. Mouse model of colonic adenomacarcinoma progression based on somatic Apc inactivation. Cancer Res. 67:9721-9730. http://dx.doi.org/10.1158/0008-5472.CAN-07-2735.
46. Hryniuk A, Grainger S, Savory JG, Lohnes D. 2012. Cdx function is required for maintenance of intestinal identity in the adult. Dev. Biol. 363:426-437. http://dx.doi.org/10.1016/j.ydbio.2012.01.010.
47. Verzi MP, Hatzis P, Sulahian R, Philips J, Schuijers J, Shin H, Freed E, Lynch JP, Dang DT, Brown M, Clevers H, Liu XS, Shivdasani RA. 2010. TCF4 and CDX2, major transcription factors for intestinal function, converge on the same cis-regulatory regions. Proc. Natl. Acad. Sci. U. S. A. 107:15157-15162. http://dx.doi.org/10.1073/pnas.1003822107.
48. Stewart J, Evan G, Watson J, Sikora K. 1986. Detection of the c-myc oncogene product in colonic polyps and carcinomas. Br. J. Cancer 53:1-6. http://dx.doi.org/10.1038/bjc.1986.1.
49. Sugio K, Kurata S, Sasaki M, Soejima J, Sasazuki T. 1988. Differential expression of c-myc gene and c-fos gene in premalignant and malignant tissues from patients with familial polyposis coli. Cancer Res. 48:4855-4861.
50. Tsuboi K, Hirayoshi K, Takeuchi K, Sabe H, Shimada Y, Ohshio G, Tobe T, Hatanaka M. 1987. Expression of the c-myc gene in human gastrointestinal malignancies. Biochem. Biophys. Res. Commun. 146: 699-704. http://dx.doi.org/10.1016/0006-291X(87)90585-7.
51. Takahashi M, Nakatsugi S, Sugimura T, Wakabayashi K. 2000. Frequent mutations of the beta-catenin gene in mouse colon tumors induced by azoxymethane. Carcinogenesis 21:1117-1120. http://dx.doi.org/10.1093/carcin/21.6.1117.
52. Jamieson T, Clarke M, Steele CW, Samuel MS, Neumann J, Jung A, Huels D, Olson MF, Das S, Nibbs RJ, Sansom OJ. 2012. Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis. J. Clin. Invest. 122:3127-3144. http://dx.doi.org/10.1172/JCI61067.
53. Rosenberg JM, Welch JP. 1985. Carcinoid tumors of the colon. A study of 72 patients. Am. J. Surg. 149:775-779.
54. Chawengsaksophak K, James R, Hammond VE, Kontgen F, Beck F. 1997. Homeosis and intestinal tumours in Cdx2 mutant mice. Nature 386:84-87. http://dx.doi.org/10.1038/386084a0.
55. Aoki K, Tamai Y, Horiike S, Oshima M, Taketo MM. 2003. Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+/Delta716 Cdx2+/-compound mutant mice. Nat. Genet. 35:323-330. http://dx.doi.org/10.1038/ng1265.
56. Taketo MM. 2006. Mouse models of gastrointestinal tumors. Cancer Sci. 97:355-361. http://dx.doi.org/10.1111/j.1349-7006.2006.00190.x.
57. Prochownik EV. 2004. c-Myc as a therapeutic target in cancer. Expert Rev. Anticancer Ther. 4:289-302. http://dx.doi.org/10.1586/14737140.4.2.289.
58. Delmore JE, Issa GC, Lemieux ME, Rahl PB, Shi J, Jacobs HM, Kastritis E, Gilpatrick T, Paranal RM, Qi J, Chesi M, Schinzel AC, McKeown MR, Heffernan TP, Vakoc CR, Bergsagel PL, Ghobrial IM, Richardson PG, Young RA, Hahn WC, Anderson KC, Kung AL, Bradner JE, Mitsiades CS. 2011. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146:904-917. http://dx.doi.org/10.1016/j.cell.2011.08.017.
59. Zirath H, Frenzel A, Oliynyk G, Segerstrom L, Westermark UK, Larsson K, Munksgaard Persson M, Hultenby K, Lehtio J, Einvik C, Pahlman S, Kogner P, Jakobsson PJ, Arsenian Henriksson M. 2013. MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells. Proc. Natl. Acad. Sci. U. S. A. 110:10258-10263. http://dx.doi.org/10.1073/pnas.1222404110.
60. Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, Fedorov O, Morse EM, Keates T, Hickman TT, Felletar I, Philpott M, Munro S, McKeown MR, Wang Y, Christie AL, West N, Cameron MJ, Schwartz B, Heightman TD, La Thangue N, French CA, Wiest O, Kung AL, Knapp S, Bradner JE. 2010. Selective inhibition of BET bromodomains. Nature 468:1067-1073. http://dx.doi.org/10.1038/nature09504.
61. Hammoudeh DI, Follis AV, Prochownik EV, Metallo SJ. 2009. Multiple independent binding sites for small-molecule inhibitors on the oncoprotein c-Myc. J. Am. Chem. Soc. 131:7390-7401. http://dx.doi.org/10.1021/ja900616b.
62. Wang H, Hammoudeh DI, Follis AV, Reese BE, Lazo JS, Metallo SJ, Prochownik EV. 2007. Improved low molecular weight Myc-Max inhibitors. Mol. Cancer Ther. 6:2399-2408. http://dx.doi.org/10.1158/1535-7163.MCT-07-0005.